Liquid biopsies, which detect cancer cells or DNA in the blood, are emerging as a non-invasive alternative to traditional biopsies. This technology is particularly promising for monitoring breast cancer progression and response to treatment, providing a quicker and less invasive option for patients. It could potentially be used for early detection in the future, offering a significant advance in breast cancer care.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.